Cancer Science & Therapy

Foteini Karasavvidou

Publications

• Research Article
  CD10 and Endothelin-1 are Inversely Expressed in Early Prostate Cancer and Predict Psa Failure after Radical Prostatectomy
  Author(s): Panagiotis J. Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, George Moutzouris, Anna Patrikidou, Ioannis A. Voutsadakis, Kassiani Kapatou, Danai D. Daliani, Michael D. Melekos and Christos N. PapandreouPanagiotis J. Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, George Moutzouris, Anna Patrikidou, Ioannis A. Voutsadakis, Kassiani Kapatou, Danai D. Daliani, Michael D. Melekos and Christos N. Papandreou
  
  Background: Loss of the membrane endopeptidase CD10 plays an important role in the development of neuropeptide-mediated androgen-independent prostate cancer cell growth. The aim of this study was to investigate the potential prognostic value of the CD10/neuropeptide axis with regard to prostate-specific antigen (PSA) failure after radical prostatectomy in early prostate cancer patients. Methods: Tumor samples from 70 early prostate cancer patients who underwent radical prostatectomy were immunohistochemically evaluated for expression of CD10 and endothelin-1 (ET-1). The examined parameters were prospectively correlated with time to PSA failure and combined with Gleason grade and pathological TNM stage. Results: Membranous and apical cytoplasmic expression of CD10 was directly correlated wit.. Read More»
  DOI: 10.4172/1948-5956.S1-005

  Abstract PDF